Scancell Holdings plc (LON:SCLP - Get Free Report)'s stock price shot up 18% on Monday . The company traded as high as GBX 10.24 ($0.14) and last traded at GBX 10 ($0.13). 4,580,422 shares traded hands during trading, an increase of 461% from the average session volume of 816,381 shares. The stock had previously closed at GBX 8.48 ($0.11).
Scancell Stock Performance
The company has a market cap of £109.27 million, a price-to-earnings ratio of -16.18 and a beta of 0.35. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42. The stock's fifty day simple moving average is GBX 8.55 and its two-hundred day simple moving average is GBX 10.82.
Scancell (LON:SCLP - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. Equities research analysts anticipate that Scancell Holdings plc will post -2.5361112 EPS for the current year.
About Scancell
(
Get Free Report)
Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
Featured Stories
Before you consider Scancell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scancell wasn't on the list.
While Scancell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
